Combination therapy with tazarotene plus a topical corticosteroid for the treatment of plaque psoriasis

British Journal of Dermatology, Supplement

Volumn 140, Issue 54, 1999, Pages 18-23

  Gollnick, H ^b   Menter, A ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Combination; Corticosteroid; Psoriasis; Tazarotene; Topical

Indexed keywords

FLUOCINOLONE ACETONIDE; FLUOCINONIDE; MOMETASONE FUROATE; TAZAROTENE;

CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; DRUG POTENCY; DRUG TOLERABILITY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PSORIASIS; SKIN MANIFESTATION; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0032907050     PISSN: 0366077X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1999.140s54018.x     Document Type: Conference Paper

References (27)

1. van de Kerkbof PCM, Volden G. Gollnick H. Comparisons and combinations. In: Textbook of Psoriasis (Mier PD, van de Kerkhof PCM, eds.). Edinburgh: Churchill Livingstone, 1986; 268-75.
2. Weinstein GD, White GM. An approach to the treatment of moderate to severe psoriasis with rotational therapy. J Am Acad Dermatol 1993; 28: 454-9.
3. Menter MA, See J-A, Amend WJC et al. Proceedings of the Psoriasis Combination and Rotation Therapy Conference, Deer Valley, Utah, Oct 7-9, 1994. J Am Acad Dermatol; 1996; 34: 315-21.
4. Gollnick H. Oral retinoids. . . . .efficacy and toxicity in psoriasis. Br J Dermatol 1996; 135: 6-17.
5. Liem WH, McCullough JL, Weinstein GD. Effectiveness of topical therapy for psoriasis: results of a national survey. Cutis 1995; 55: 306-10.
6. Theeuwes M, Bright R. Use of a hydrocolloid dressing in combination with a topical steroid in plaque psoriasis. Cutis 1996; 57: 48-50.
7. MacDonald A, McMinn RMH, Fry L. Effect of retinoic acid in psoriasis, II. Long term study. Br J Dermatol 1972; 87: 256-60.
8. Orfanos CE, Schmidt HW, Mahrle G et al. Retinoic acid in psoriasis: its value for topical therapy with and without corticosteroids. Clinical, histological and electron microscopical studies on 44 hospitalized patients with extensive psoriasis. Br J Dermatol 1973; 88: 167-82.
9. Günther S. The therapeutic value of retinoic acid in chronic discoid, acute guttate, and erythrodermic psoriasis: clinical observations on 25 patients. Br J Dermatol 1973; 89: 515-17.
10. Kaidbey KH, Petrozzi JW, Kligman AM. Treatment of psoriasis with topically applied tretinoin and steroid ointment. Arch Dermatol 1975; 111: 1001-3.
11. Nagpal S, Patel S, Asano AT et al. Tazarotene-induced gene 1 (TIG1), a novel retinoic acid receptor-responsive gene in skin. J Invest Dermatol 1996; 106: 269-74.
12. Nagpal S, Patel S, Jacobe H et al. Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin. J Invest Dermatol 1997; 109: 91-5.
13. Duvic M, Nagpal S, Asano AT, Chandraratna RAS. Molecular mechanisms of tazarotene action in psoriasis. J Am Acad Dermatol 1997; 37: S18-S24.
14. Esgleyes-Ribot T, Chandraratna RA, Lew-Kaya DA et al. Response of psoriasis to a new topical retinoid, AGN 190168. J Am Acad Dermatol 1994; 30: 581-90.
15. de Jong EM, Ferrier CM, de Zwart A et al. Effects of topical treatment with budesonide on parameters for epidermal proliferation, keratinization and inflammation in psoriasis. J Dermatol Sci 1995; 9: 185-94.
16. Phillips WG, Breathnach SM. Psoriasis: immune indicators and treatment. Drugs 1994; 1: 157-67.
17. Greaves MW, Weinstein GD. Treatment of psoriasis. N Engl J Med 1995; 332: 581-8.
18. Kligman LH, Schwartz E, Lesnik RH, Mezick JA. Topical tretinoin prevents corticosteroid-induced atrophy without lessening the anti-inflammatory effect. Curr Prob Dermatol 1995; 21: 79-88.
19. McMichael AJ, Griffiths CEM, Talwar HS et al. Concurrent application of tretinoin (retinoic acid) partially protects against corticosteroid-induced epidermal atrophy. Br J Dermatol 1996; 135: 60-4.
20. Weinstein GD. Tazarotene gel: Efficacy and safety in plaque psoriasis. J Am Acad Dermatol 1997; 37: S33-8.
21. Weller PA. Psoriasis, Med J Aust 1996; 165: 216-21.
22. Guzzo C. Recent advances in the treatment of psoriasis. Dermatol Clin 1997; 15: 59-68.
23. Lebwohl MG. Breneman DL, Goffe BS et al. Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis. J Am Acad Dermatol 1998; 39: 590-6.
24. Milliken G, Johnson D. Analysis of messy data (Volume 1). Designed experiments. Belmont, California: Lifetime Learning Publications, 1984; 31-3.
25. Peace K. Biopharmaceutical Statistics for Drug Development, New York: Marcel-Dekker, 1988; 415-21.
26. Fleiss JL. The Design and Analysis of Clinical Experiments. New York: John Wiley, 1986.
27. Berry D, Statistical Methodology in the Pharmaceutical Sciences. New York: Marcel-Dekker, 1990.